| The oncogenic versions of the Ret and Trk tyrosine kinases bind Shc and Grb2 adaptor proteins. | None |
| Expression of the ret proto-oncogene product in human normal and neoplastic tissues of neural crest origin. | None |
| A Drosophila homolog of human proto-oncogene ret transiently expressed in embryonic neuronal precursor cells including neuroblasts and CNS cells. | None |
| Expression of the c-ret proto-oncogene during mouse embryogenesis. | None |
| In vitro irradiation is able to cause RET oncogene rearrangement. | None |
| Structural analysis of the human ret proto-oncogene using exon trapping. | None |
| Motifs of cadherin- and fibronectin type III-related sequences and evolution of the receptor-type-protein tyrosine kinases: sequence similarity between proto-oncogene ret and cadherin family. | None |
| Characterization of the ret proto-oncogene products expressed in mouse L cells. | None |
| cDNA cloning of mouse ret proto-oncogene and its sequence similarity to the cadherin superfamily. | None |
| Mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A (Sipple s syndrome). | None |
| Mutation analysis of the RET proto-oncogene in Dutch families with MEN 2A, MEN 2B and FMTC: two novel mutations and one de novo mutation for MEN 2A. | None |
| Putting the bits and pieces of the RET proto-oncogene puzzle together. | None |
| Oncogenic RET receptors display different autophosphorylation sites and substrate binding specificities. | None |
| The full oncogenic activity of Ret/ptc2 depends on tyrosine 539, a docking site for phospholipase Cgamma. | None |
| Identification of tyrosine residues that are essential for transforming activity of the ret proto-oncogene with MEN2A or MEN2B mutation. | None |
| Functional receptor for GDNF encoded by the c-ret proto-oncogene. | None |
| A mutation in the RET proto-oncogene in Hirschsprung s disease affects the tyrosine kinase activity associated with multiple endocrine neoplasia type 2A and 2B. | None |
| C618R mutation in exon 10 of the RET proto-oncogene in a kindred with multiple endocrine neoplasia type 2A and Hirschsprung s disease. | None |
| Mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2. | None |
| [Detection of RET-proto-oncogene mutations in the diagnosis of Type 2 endocrine neoplasia (MEN 2)]. | None |